Halozyme to Participate in the TD Cowen 45th Annual Healthcare Conference
Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced that Dr. Helen Torley, president and chief executive officer, will present and host investor meetings at the TD Cowen 45th Annual Healthcare Conference.
TD Cowen analyst Andrew Sherman raised the firm’s price target on Axon (AXON) to $725 from $700 and keeps a Buy rating on the shares. The firm ...
AllianceBernstein (NYSE:AB) was downgraded at TD Cowen after Equitable Holdings (NYSE:EQH) announced a tender offer for up to ...
Microsoft Corp. has canceled some leases for US data center capacity, according to TD Cowen, raising broader concerns over ...
TD Cowen analyst William Katz maintained a Buy rating on Apollo Global Management (APO – Research Report) today and set a price target of ...
Textron (NYSE:TXT – Get Free Report) was upgraded by investment analysts at TD Cowen to a “hold” rating in a report released ...
Mit Blick auf den KI-Nachfrage-Ausblick lässt ein Bericht der Investmentbank TD Cowen aufhorchen: Microsoft hat demnach ...
Microsoft Corp. has canceled some leases for US data center capacity, according to TD Cowen, raising broader concerns over ...
TD Cowen cut shares of AllianceBernstein (NYSE:AB – Free Report) from a buy rating to a hold rating in a research note issued to investors on Tuesday, Marketbeat Ratings reports. TD Cowen currently ...
TD Cowen analyst David Deckelbaum maintained a Buy rating on Permian Resources (PR – Research Report) today and set a price target of $19.00.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback